All Stories

  1. Polynuclear Silver(I)–Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study
  2. Structure and solution biospeciation on tricarbonylrhenium(I) complexes of mercaptopyrimidines with multifaceted biological activity
  3. Silver(I) complexes with antifungal drug econazole: Structural characterization and antimicrobial activity study
  4. Dinuclear Gallium(III) Complex With 1,3‐Propanediamine‐N,N′‐Diacetate: Structural Characterization, Antimicrobial Activity, and DNA/BSA Interactions
  5. Silver(i) complexes containing antifungal azoles: significant improvement of the anti-Candida potential of the azole drug after its coordination to the silver(i) ion
  6. Organometallic Ru(ii), Rh(iii) and Re(i) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity
  7. Synergy of experimental and computational chemistry: structure and biological activity of Zn(ii) hydrazone complexes
  8. Nickel(II) and nickel(III) thiosemicarbazone and hydrazone complexes: An unexpected journey
  9. Reactions of Medicinal Gold Compounds with Cathepsin B Explored through Electrospray Mass Spectrometry Measurements
  10. Correlating Structure and KA2 Catalytic Activity of ZnII Hydrazone Complexes
  11. Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds
  12. Novel Organoruthenium(II) Complex C1 Selectively Inhibits Butyrylcholinesterase without Side Effects on Neuromuscular Transmission
  13. Copper(ii) and silver(i) complexes with dimethyl 6-(pyrazine-2-yl)pyridine-3,4-dicarboxylate (py-2pz): the influence of the metal ion on the antimicrobial potential of the complex
  14. Silver(I) Complexes with Clinically Used Azoles: Synthesis, Structural Characterization and Antimicrobial Evaluation
  15. Coordination preferences of NNO and NNS Schiff base ligands with Co(III) complexes: Synthesis, characterization and DFT calculation
  16. Nanosecond electric pulses are equally effective in electrochemotherapy with cisplatin as microsecond pulses
  17. Kinetic Characterization of Cerium and Gallium Ions as Inhibitors of Cysteine Cathepsins L, K, and S
  18. Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
  19. Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
  20. Zinc(II) Complexes with Dimethyl 2,2′-Bipyridine-4,5-dicarboxylate: Structure, Antimicrobial Activity and DNA/BSA Binding Study
  21. Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile
  22. Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
  23. Clinically used antifungal azoles as ligands for gold(iii) complexes: the influence of the Au(iii) ion on the antimicrobial activity of the complex
  24. Cu(ii), Mn(ii) and Zn(ii) complexes of hydrazones with a quaternary ammonium moiety: synthesis, experimental and theoretical characterization and cytotoxic activity
  25. Pyrithione metal (Cu, Ni, Ru) complexes as photo-catalysts for styrene oxide production
  26. Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes
  27. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
  28. Comparison of Solution Chemical Properties and Biological Activity of Ruthenium Complexes of Selected β-Diketone, 8-Hydroxyquinoline and Pyrithione Ligands
  29. Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
  30. Large enhancement of photocatalytic activity in ZnO thin films grown by plasma-enhanced atomic layer deposition
  31. Structural Characterization, Antimicrobial Activity and BSA/DNA Binding Affinity of New Silver(I) Complexes with Thianthrene and 1,8-Naphthyridine
  32. Structure of Biologically Active Benzoxazoles: Crystallography and DFT Studies
  33. Tailoring copper(ii) complexes with pyridine-4,5-dicarboxylate esters for anti-Candida activity
  34. Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential
  35. Synthesis, X-ray structures and magnetic properties of Ni(II) complexes of heteroaromatic hydrazone
  36. Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin
  37. Synthesis, Characterization, Catalytic Activity, and DFT Calculations of Zn(II) Hydrazone Complexes
  38. Cobalt(II), Zinc(II), Iron(III), and Copper(II) Complexes Bearing Positively Charged Quaternary Ammonium Functionalities: Synthesis, Characterization, Electrochemical Behavior, and SOD Activity
  39. Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
  40. Structural and functional characterization of an organometallic ruthenium complex as a potential myorelaxant drug
  41. Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS
  42. Silver(i) complexes with different pyridine-4,5-dicarboxylate ligands as efficient agents for the control of cow mastitis associated pathogens
  43. Synthesis, X-ray structure and DFT calculation of magnetic properties of binuclear Ni(II) complex with tridentate hydrazone-based ligand
  44. Combined Experimental and Theoretical Investigation of the Origin of Magnetic Anisotropy in Pentagonal Bipyramidal Isothiocyanato Co(II), Ni(II) and Fe(III) Complexes With Quaternary Ammonium-functionalized 2,6-Diacetylpyridine Bisacylhydrazone
  45. Towards Identification of Essential Structural Elements of Organoruthenium(II)‐Pyrithionato Complexes for Anticancer Activity
  46. Covalent versus Noncovalent Binding of Ruthenium η 6 ‐ p ‐Cymene Complexes to Zinc‐Finger Protein NCp7
  47. Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity
  48. What Is the Nature of Interactions of BF4–, NO3–, and ClO4– to Cu(II) Complexes with Girard’s T Hydrazine? When Can Binuclear Complexes Be Formed?
  49. Highly-efficient N-arylation of imidazole catalyzed by Cu(II) complexes with quaternary ammonium-functionalized 2-acetylpyridine acylhydrazone
  50. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties
  51. Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
  52. Anti-cancer organoruthenium(ii) complexes and their interactions with cysteine and its analogues. A mass-spectrometric study
  53. Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer
  54. Synthesis, Biological Evaluation and Docking Studies of Benzoxazoles Derived from Thymoquinone
  55. Synthesis, structures and magnetic properties of octahedral Co(III) complexes of heteroaromatic hydrazones with tetraisothiocyanato Co(II) anions
  56. Organoruthenium Prodrugs as a New Class of Cholinesterase and Glutathione-S-Transferase Inhibitors
  57. Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines
  58. C-H Bond Activation by a Ruthenium(II) β -Diketonate Complex: A Mechanistic Study
  59. Structural diversity of isothiocyanato Cd(II) and Zn(II) Girard’s T hydrazone complexes in solution and solid state: effect of H-bonding on coordination number and supramolecular assembly of Cd(II) complex in solid state
  60. Crystal structures and DFT calculations of mixed chloride-azide zinc(II) and chloride-isocyanate cadmium(II) complexes with the condensation product of 2-quinolinecarboxaldehyde and Girard's T reagent
  61. Concomitant polymorphism in an organometallic ruthenium(II) complex with an N,N′-donor ligand
  62. Manganese(II) complexes of the quinolone family member flumequine: Structure, antimicrobial activity and affinity for albumins and calf-thymus DNA
  63. Correction to: Exploration of selected electronic characteristics of half-sandwich organoruthenium(II) β-diketonate complexes
  64. Exploration of selected electronic characteristics of half-sandwich organoruthenium(II) β-diketonate complexes
  65. Molecular Structures and Spin-States of Pseudohalide Metal Complexes with Hydrazones of Girard's T Reagent
  66. A new class of platinum(ii) complexes with the phosphine ligand pta which show potent anticancer activity
  67. How zinc ions shift and enhance the nucleotide's fluorescence spectra
  68. Extending the family of quinolone antibacterials to new copper derivatives: self-assembly, structural and topological features, catalytic and biological activity
  69. Crystal structures, magnetic properties and DFT study of cobalt(II) azido complexes with the condensation product of 2-quinolinecarboxaldehyde and Girard’s T reagent
  70. Synthesis, characterization and antimicrobial activity of isothiocyanato Fe(III) Girard's t hydrazone complex
  71. Synthesis, characterization, DFT calculations and antimicrobial activity of Cd(II) complexes with the condensation product of 2-quinolinecarboxaldehyde and Girard’s T reagent
  72. Synthesis, crystal structures and antimicrobial activity of azido and isocyanato Zn(II) complexes with the condensation product of 2-quinolinecarboxaldehyde and Girard’s T reagent
  73. Synthesis, characterization and crystal structures of two pentagonal-bipyramidal Fe(III) complexes with dihydrazone of 2,6-diacetylpyridine and Girard's T reagent. Anticancer properties of various metal complexes of the same ligand
  74. Synthesis, crystal structure, magnetic properties and DFT study of dinuclear Ni(II) complex with the condensation product of 2-quinolinecarboxaldehyde and Girard’s T reagent
  75. Synthesis and Structural Evaluation of Organo-Ruthenium Complexes with β-Diketonates
  76. β-Diketones as Scaffolds for Anticancer Drug Design - From Organic Building Blocks to Natural Products and Metallodrug Components
  77. Copper(II) complexes with gatifloxacin
  78. Cobalt(II) complexes of sparfloxacin
  79. Synthesis, characterization, DFT calculations and antimicrobial activity of pentagonal-bipyramidal Zn(II) and Cd(II) complexes with 2,6-diacetylpyridine-bis(trimethylammoniumacetohydrazone)
  80. Co-NSAIDs
  81. Interactions of two cytotoxic organoruthenium(II) complexes with G-quadruplex
  82. Interactions of the “piano-stool” [ruthenium(II)(η6-arene)(quinolone)Cl]+complexes with water; DFT computational study
  83. Synthesis, characterization and antimicrobial activity of pentagonal-bipyramidal isothiocyanato Co(II) and Ni(II) complexes with 2,6-diacetylpyridine bis(trimethylammoniumacetohydrazone)
  84. Synthesis and characterization of ML and ML2 metal complexes with amino acid substituted bis(2-picolyl)amine ligands
  85. Pyrithione-based ruthenium complexes as inhibitors of aldo–keto reductase 1C enzymes and anticancer agents
  86. Structure and biological activities of metal complexes of flumequine
  87. Clioquinol–ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity
  88. Investigation of antitumor potential of Ni(II) complexes with tridentate PNO acylhydrazones of 2-(diphenylphosphino)benzaldehyde and monodentate pseudohalides
  89. Ruthenium complexes as inhibitors of 15-lipoxygenase-1
  90. Synthesis, crystal structures, and antimicrobial activity of square-planar chloride and isocyanate Ni(II) complexes with the condensation product of 2-(diphenylphosphino)benzaldehyde and Girard’s T reagent
  91. New synthetic routes for the preparation of ruthenium-1,10-phenanthroline complexes. Tests of cytotoxic and antibacterial activity of selected ruthenium complexes
  92. Ruthenium complexes as inhibitors of the aldo–keto reductases AKR1C1–1C3
  93. Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates
  94. Special Issue: Practical Applications of Metal Complexes
  95. Experimental and theoretical investigation of octahedral and square-planar isothiocyanato complexes of Ni(II) with acylhydrazones of 2-(diphenylphosphino)benzaldehyde
  96. Manganese(II)–sparfloxacinato complexes
  97. Cobalt-oxolinato complexes
  98. New method for the speciation of ruthenium-based chemotherapeutics in human serum by conjoint liquid chromatography on affinity and anion-exchange monolithic disks
  99. Synthesis, characterization, DFT calculation and biological activity of square-planar Ni(II) complexes with tridentate PNO ligands and monodentate pseudohalides. Part II
  100. Cobalt(II) complexes of enrofloxacin
  101. Modulation of Activity of Known Cytotoxic Ruthenium(III) Compound (KP418) with Hampered Transmembrane Transport in Electrochemotherapy In Vitro and In Vivo
  102. New Water-Soluble Ruthenium(II) Terpyridine Complexes for Anticancer Activity: Synthesis, Characterization, Activation Kinetics, and Interaction with Guanine Derivatives
  103. Synthesis and Biological Evaluation of Organoruthenium Complexes with Azole Antifungal Agents. First Crystal Structure of a Tioconazole Metal Complex
  104. Zinc-tolfenamato
  105. Analysis of the structures of the Cu(I) and Cu(II) complexes with 3-acetylpyridine and thiocyanate
  106. Manganese(II) complexes of tolfenamic acid
  107. Structural characterization and biological evaluation of a clioquinol–ruthenium complex with copper-independent antileukaemic activity
  108. Zinc complexes of mefenamic acid
  109. Synthesis, characterization, DFT calculations and biological activity of derivatives of 3-acetylpyridine and the zinc(II) complex with the condensation product of 3-acetylpyridine and semicarbazide
  110. New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
  111. Manganese(II) complexes of niflumic acid
  112. Zinc complexes of oxolinic acid, flumequine, enrofloxacin
  113. Novel Organoruthenium(II) β-Diketonates as Catalysts for Ortho Arylation via C–H Activation
  114. Zinc complexes of flumequine
  115. Copper complexes with ofloxacin and norfloxacin - synthesis, structure na bioactivity
  116. Copper(II) complexes of flumequine
  117. Synthesis and Biological Evaluation of the Thionated Antibacterial Agent Nalidixic Acid and Its Organoruthenium(II) Complex
  118. Cobalt(II)-tolfenamato complexes
  119. Factors that influence the antiproliferative activity of half sandwich RuII–[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives
  120. Copper - diflunisal
  121. Interactions of Metal Ions with DNA, Its Constituents and Derivatives, which may be Relevant for Anticancer Research
  122. Nickel–quinolones-bipyam complexes
  123. Synthesis, characterization, cytotoxic activity and DNA binding properties of the novel dinuclear cobalt(III) complex with the condensation product of 2-acetylpyridine and malonic acid dihydrazide
  124. Physicochemical Studies and Anticancer Potency of Ruthenium η6-p-Cymene Complexes Containing Antibacterial Quinolones
  125. Copper(II) complexes of naproxen / diclofenac
  126. 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity
  127. Zinc complexes of sparfoxacin - levofloxacin
  128. First Ruthenium Organometallic Complex of Antibacterial Agent Ofloxacin. Crystal Structure and Interactions with DNA
  129. Pyridyl Conjugated 1,2,3-Triazole is a Versatile Coordination Ability Ligand Enabling Supramolecular Associations
  130. Di-μ-chlorido-bis{chlorido[(R)/(S)-1,5-diphenyl-3-(2-pyridyl-κN)-2-pyrazoline-κN2]zinc(II)}
  131. Nickel complexes of flumequine
  132. Intermolecular C—H...π interactions in 1,5-diphenyl-3-(2-pyridyl)-2-pyrazoline
  133. Click-Triazole N2 Coordination to Transition-Metal Ions Is Assisted by a Pendant Pyridine Substituent
  134. Strong Correlations in Highly Electron-Doped Zn(II)-DNA Complexes
  135. Nickel complexes of oxolinic acid
  136. Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
  137. Magnesium complexes of ciprofloxacin
  138. Spectral properties of Eu(III) compound with antibacterial agent ciprofloxacin (cfqH). Crystal structure of [Eu(cfqH)(cfq)(H2O)4]Cl2·4.55H2O
  139. Combined therapy of the antimetastatic compound NAMI-A and electroporation on B16F1 tumour cells in vitro
  140. Erratum to: Synthesis, characterization and DNA binding of magnesium-ciprofloxacin (cfH) complex [Mg(cf)2] · 2.5H2O [J. Inorg. Biochem. 100 (2006) 1705–1713]
  141. Optical spectra of wet and dry M -DNA
  142. Experimental electron density study of a complex between copper(ii) and the antibacterial quinolone family member ciprofloxacin
  143. X-Ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones – racemic ofloxacin and its S-form, levofloxacin
  144. catena-Poly[[[tetrakis(μ-acetato-κ2O:O′)dirhodium(II)]-μ-[1,3-bis(dimethylamino)propan-2-ol-κ2N:N′]] tetrahydrofuran hemisolvate]
  145. Synthesis, characterization and DNA binding of magnesium–ciprofloxacin (cfH) complex [Mg(cf)2] · 2.5H2O
  146. Ruthenium complexes with purine derivatives: Syntheses, structural characterization and preliminary studies with plasmidic DNA
  147. Mixed-valence Cu(II)/Cu(I) complex of quinolone ciprofloxacin isolated by a hydrothermal reaction in the presence of l-histidine: comparison of biological activities of various copper–ciprofloxacin compounds
  148. Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives
  149. A novel copper(II) complex with 1,10-phenanthroline and ciprofloxacin
  150. Influence of copper(II) and magnesium(II) ions on the ciprofloxacin binding to DNA
  151. Ruthenium(III)-DMSO complexes of the antiherpes drug acyclovir
  152. Characterization of ciprofloxacin binding to the linear single- and double-stranded DNA
  153. Interactions of oxovanadium(IV) and the quinolone family member—ciprofloxacin
  154. Crystal Structure of Ciprofloxacin Hydrochloride 1.34-Hydrate.
  155. Interaction between ciprofloxacin and DNA mediated by Mg2+-ions
  156. The interactions of metal ions with quinolone antibacterial agents
  157. Novel RuIII-DMSO Complexes of the Antiherpes Drug Acyclovir
  158. Erratum to In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds
  159. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds
  160. Biological Activity of Some Magnesium(II) Complexes of Quinolones
  161. Complexes of copper (II) acetate with nicotinamide: preparation, characterization and fungicidal activity; crystal structures of [Cu2 (O2CCH3)4 (nia)] and [Cu2 (O2CCH3)4 (nia)2]
  162. NMR Investigation of the Copper(II)‐Ciprofloxacin System
  163. New studies in the copper(II) acyclovir (acv) system. NMR relaxation studies and the X-ray crystal structure of [Cu(acv)2(H2O)2](NO3)2
  164. Antibacterial tests of Bismuth(III)–Quinolone (Ciprofloxacin, cf) compounds against Helicobacter pylori and some other bacteria. Crystal structure of (cfH2)2[Bi2Cl10]·4H2O
  165. Complexes of copper(II) carboxylates with 2-aminoethanol - syntheses, characterization and fungicidal activity; crystal structure of Cu(O2CC8H17)2(NH2C2H4OH)2
  166. Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells
  167. Boron Complex of a Member of the Quinolone Family
  168. Crystal structure of ciprofloxacin hexahydrate and its characterization
  169. Crystal structure and characterization of the bismuth(III) compound with quinolone family member (ciprofloxacin). Antibacterial study
  170. Synthesis, crystal structure, and characterization of two metal-quinolone compounds
  171. Synthesis and characterization of copper(II) coordination compounds with acyclovir: crystal structure of triaquabis [9-{(2-hydroxyethoxy)methyl>guanine] copper(II) nitrate (V) hydrate
  172. An Adduct of Magnesium Sulfate with a Member of the Quinolone Family (Ciprofloxacin)
  173. Comparison of the thermal stability of ciprofloxacin and its compounds
  174. The crystal structure and characterization of a copper(II) complex with a guanosine-5′-monophosphate analog (acyclovir monophosphate)
  175. Synthesis, crystal structure, and characterization of three novel compounds of the quinolone family member (norfloxacin)
  176. Complex formation between some metals and a quinolone family member (ciprofloxacin)
  177. Synthesis, characterization, and crystal structure of a copper(II) complex with quinolone family member (ciprofloxacin): bis(1)-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazin-1ylquinoline-3-carboxylate) copper(II) chloride hexahydrate
  178. Synthesis and structure of diaquadichlorobis {9-[(2-hydroxyethoxy)methyl]guanine} copper(II)